Is a patient with normal Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) levels but low testosterone considered to have primary hypogonadism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal LH and FSH with Low Testosterone is NOT Primary Hypogonadism

A patient with normal LH and FSH levels but low testosterone does not have primary hypogonadism, but rather has secondary hypogonadism or adult-onset hypogonadism. 1

Types of Hypogonadism

  • Primary hypogonadism (hypergonadotropic): Caused by testicular dysfunction with low testosterone levels and elevated LH and FSH levels above normal as a compensatory response 1
  • Secondary hypogonadism (hypogonadotropic): Results from impairment of the hypothalamic-pituitary-gonadal axis with low testosterone and normal or low LH and FSH levels 1, 2
  • Adult-onset hypogonadism: Characterized by testosterone deficiency with normal or low gonadotropins, suggesting physiologic failure of both the testicles and hypothalamic-pituitary system 1

Diagnostic Classification Based on Laboratory Values

  • Normal LH/FSH with low testosterone indicates secondary hypogonadism or adult-onset hypogonadism 1
  • In primary hypogonadism, testosterone levels are low while LH and FSH are elevated above normal 1, 3
  • The pattern of normal gonadotropins with low testosterone is inconsistent with primary testicular failure 2, 4

Common Causes of Secondary Hypogonadism

  • Obesity: Increased aromatization of testosterone to estradiol in adipose tissue, with subsequent estradiol-mediated negative feedback suppressing pituitary LH secretion 1
  • Medications: Opiates, GnRH agonists/antagonists, glucocorticoids, estrogens, progestogens 1
  • Pituitary disorders: Tumors, inflammatory conditions, traumatic brain injury 1
  • Systemic conditions: Type 2 diabetes, metabolic syndrome, chronic illness 1
  • Functional causes: Nutritional deficiencies, excessive exercise, stress 1, 2

Evaluation Approach

  • Confirm low testosterone with repeat morning measurements (between 8-10 AM) 1
  • Measure free testosterone by equilibrium dialysis, especially in obese patients 1
  • Check sex hormone-binding globulin levels, as low levels can affect total testosterone measurements 1
  • Consider further evaluation for secondary hypogonadism including:
    • Prolactin levels to rule out hyperprolactinemia 1
    • Iron saturation studies 1
    • Pituitary function testing 1
    • MRI of the sella turcica if clinically indicated 1

Clinical Implications

  • Secondary hypogonadism patients can potentially achieve both fertility and normal testosterone levels with appropriate treatment 1
  • Primary hypogonadism patients can only receive testosterone therapy, which compromises fertility by suppressing the HPG axis 1
  • In men interested in fertility, testosterone monotherapy should not be prescribed as it can suppress spermatogenesis 1
  • Treatment options for secondary hypogonadism may include:
    • Lifestyle modifications for obesity-related hypogonadism 1
    • Gonadotropin therapy (hCG, FSH) for those desiring fertility 1
    • Addressing underlying conditions (e.g., treating hyperprolactinemia) 1

Key Takeaway

The combination of normal LH/FSH with low testosterone definitively rules out primary hypogonadism and points to secondary hypogonadism or adult-onset hypogonadism, requiring evaluation of the hypothalamic-pituitary axis and potential underlying causes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Epidemiology, diagnosis, and treatment of male hypogonadotropic hypogonadism.

Journal of endocrinological investigation, 2009

Research

Hypogonadism: Its Prevalence and Diagnosis.

The Urologic clinics of North America, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.